Address
27–28 Eastcastle Street
Farnham, W1W 8DH
United Kingdom of Great Britain and Northern Ireland (the)
Phone
441252728001
Website
Sector
Healthcare
Industry
Biotechnology
Employees
17
First IPO Date
April 29, 2014
| Name | Title | Pay | Year Born |
| Peter John Harrison | Chief Executive Officer & Director | 362,343 | 1958 |
| Bruce Edward Heath Hiscock | Chief Financial Officer & Director | 105,844 | 1958 |
Bioventix PLC focuses on the development, manufacturing, and global provision of sheep monoclonal antibodies (SMAs) for various diagnostic purposes. The company's extensive product line features purified SMAs that facilitate testing for critical areas such as thyroid conditions, vitamin D deficiencies, cardiac health markers, detection of drugs of abuse, fertility assessments, infectious diseases, oncology, and other diverse medical indications. Additionally, Bioventix PLC offers tailored contract SMA development and specialized recombinant services. The London, UK-based firm was established in 2003.